Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.06    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €295.52m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

DIVIDEND DECLARATION & DIV TARGET '26

26 Jan 2026 15:48

RNS Number : 4050Q
CVC Income & Growth Limited
26 January 2026
Β 

26 January 2026

Β 

Β 

CVC Income & Growth Limited

Β 

Dividend Declaration and

Annual Dividend Targets for financial year 2026

Β 

The information contained within this announcement constitutes inside information.

Β 

The Board of CVC Income & Growth Limited (the Company) has declared a quarterly interim dividend of 2.7625p per ordinary Sterling Share and 1.8125c per ordinary Euro Share.

Β 

The dividend will be payable on 27 February 2026 to shareholders on the register as at the close of business on 06 February 2026 (the record date) and the corresponding ex-dividend date will be 05 February 2026.

Β 

The Board of Directors, in conjunction with the Investment Vehicle Manager, has completed its periodic review of the Company's annual dividend targets and is pleased to announce its 2026 dividend target of 9.25p per ordinary Sterling Share and 7.25c per ordinary Euro Share.Β As a result, the Company's 2026 quarterly dividends will be 2.3125p per Sterling Share and 1.8125c per Euro Share.

The Chairman of the Company, Robert Kirkby commented:Β "I am pleased to announce a dividend yield of 8.2% per ordinary Sterling Share and 6.7% per ordinary Euro Share based on the 23 January 2026 share price.

We are in a position to pay a top up dividend of 0.45p on the Sterling Share Class despite interest rates falling during 2025. With lower interest rates in Europe during 2025, no top up dividend is available on the Euro Share Class.Β 

We are delighted to retain the same dividend guidance for 2026 (9.25p per ordinary Sterling Share and 7.25c per ordinary Euro Share) as 2025 notwithstanding the current interest rate forecasts available."

Β 

-END-

Β 

Β 

The person responsible for arranging for the release of this announcement on behalf of the Company is Guerhardt Lamprecht of BNP Paribas S.A., Jersey Branch, Company Secretary.

Β 

Enquiries:

Β 

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

Β 

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVBUGDBLSDDGLL
Date   Source Headline
13th Jun 20245:30 pmRNSNet Asset Value Weekly to 07 Jun 2024
6th Jun 20245:00 pmRNSNet Asset Value Weekly to 31 May 2024
3rd Jun 20244:18 pmRNSTotal Voting Rights
30th May 202412:45 pmRNSNet Asset Value Weekly to 24 May 2024
23rd May 20245:15 pmRNSNet Asset Value Weekly to 17 May 2024
21st May 20249:37 amRNSMonthly Report
20th May 20241:34 pmRNSDirector Declaration
17th May 20246:07 pmRNSNet Asset Value Month End 30 Apr 2024
16th May 20243:51 pmRNSNet Asset Value Weekly to 10 May 2024
15th May 202410:49 amRNSIssue of Equity
10th May 20244:31 pmRNSNet Asset Value Weekly to 03 May 2024
3rd May 20249:04 amRNSNet Asset Value Weekly to 26 Apr 2024
1st May 202411:01 amRNSDividend Declaration
1st May 202411:01 amRNSTotal Voting Rights
1st May 20249:40 amRNSDirector/PDMR Shareholding
30th Apr 202410:47 amRNSDirectorate Change
30th Apr 202410:46 amRNSResult of AGM
25th Apr 20244:00 pmRNSNet Asset Value Weekly to 19 Apr 2024
24th Apr 20243:43 pmRNSDirector/PDMR Shareholding
23rd Apr 202412:02 pmRNSMonthly Report
22nd Apr 20244:55 pmRNSIssue of Equity
18th Apr 20244:53 pmRNSNet Asset Value Weekly to 12 Apr 2024
18th Apr 20247:00 amRNSMarch 2024 Tender Price
17th Apr 20245:09 pmRNSIssue of Equity
15th Apr 20245:07 pmRNSNet Asset Value Month End 28 Mar 2024
11th Apr 202411:45 amRNSNet Asset Value Weekly to 05 Apr 2024
10th Apr 20242:46 pmRNSNotice of AGM
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
2nd Apr 202411:27 amRNSNet Asset Value Weekly to 22 Mar 2024
28th Mar 20247:00 amRNSAnnual Financial Report
25th Mar 20244:09 pmRNSMonthly Report
21st Mar 20243:59 pmRNSNet Asset Value Weekly to 15 Mar 2024
15th Mar 20243:59 pmRNSNet Asset Value Month End 29 Feb 2024
14th Mar 20244:04 pmRNSNet Asset Value Weekly to 08 Mar 2024
7th Mar 20244:59 pmRNSNet Asset Value Weekly to 01 Mar 2024
6th Mar 20247:00 amRNSResults of Placing in respect of March 2024 Tender
28th Feb 20244:33 pmRNSNet Asset Value Weekly to 23 Feb 2024
22nd Feb 20244:11 pmRNSDirector/PDMR Shareholding
22nd Feb 20243:28 pmRNSNet Asset Value Weekly to 16 Feb 2024
20th Feb 20244:56 pmRNSMonthly Report
16th Feb 20244:16 pmRNSNet Asset Value Weekly to 09 Feb 2024
15th Feb 20241:49 pmRNSNet Asset Value Month End 31 Jan 2024
14th Feb 20241:00 pmRNSResult of Semi-Annual Tender Process
8th Feb 20244:41 pmRNSNet Asset Value Weekly to 02 Feb 2024
7th Feb 202410:22 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSIncrease in Annual Dividend Targets
2nd Feb 20244:01 pmRNSNet Asset Value Weekly to 26 Jan 2024
1st Feb 20244:05 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSAddition of Placing Shares as part of March Tender
30th Jan 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.